Table 3.

Incidence rate of MAT events, stratified by age: crude incidence rate of MAT events in PBSC donors

Age, years	18-29	30-39	40-49	50+
No. of donors	5896	3871	3231	1532
Donor-years	41 450	33 548	29 717	13 969
Myeloid
Donor-years	41 444	33 584	29 715	13 968
Events	1	0	1	1
Crude rate∗	2.41	0.00	3.37	7.16
95% CI	(0.341-7.13)	N/A	(0.47-23.89)	(1.01-50.82)
Lymphoid
Donor-years	41 432	33 558	29 704	13 956
Events	4	5	5	3
Crude rate∗	9.65	14.90	16.83	21.50
95% CI	(3.62-25.72)	(6.20-35.79)	(7.01-40.44)	(6.93-66.64)
Other malignancies
Donor-years	41 249	33 099	28 644	13 221
Events	49	105	225	156
Crude rate∗	118.79	317.23	785.50	1179.97
95% CI	(89.80-157.2)	(262.1-384.0)	(689.6-894.7)	(1009.5-1379.1)
Autoimmune
Donor-years	40 855	32 915	29 105	13 690
Events	137	140	115	57
Crude rate∗	335.33	425.34	395.12	416.35
95% CI	(238.7-396.4)	(360.5-501.8)	(329.2-474.2)	(321.3-539.5)
Thrombosis
Donor-years	41 345	33 401	29 409	13 821
Events	25	40	60	31
Crude rate∗	60.47	119.76	204.02	224.29
95% CI	(40.86-89.48)	(87.86-163.2)	(158.5-262.7)	(157.8-318.8)

CI, Confidence Interval

^∗Incidence rate per 100 000 person-years.